| 产品名称 | Peptides EP07873_1 | Survivin 95-104 (HLA-A*02:01) |
|---|---|
| 目录号 | EP07873_1 |
| 别名 | Survivin 95-104 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP07873_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP07873_1 | Survivin 95-104 (HLA-A*02:01)
品名：Survivin 95-104 (HLA-A*02:01)
货号：EP07873_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Survivin-derived peptide of ELTLGEFLKL sequence covering 95ï¾–104 and A*02:01 molecule.Single peptide (ELTLGEFLKL) for stimulation of human Survivin -specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. Antigen Peptide Survivin HLA-A*02:01 (ELTLGEFLKL) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
| Protein | Survivin |
| Species | Human |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication | Cancer |
